Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Europe Non-Small Cell Lung Cancer Market and Competitive Landscape 2017 - Research and Markets

Research and Markets
Posted on: 30 Nov 17

The "Europe Non-Small Cell Lung Cancer Market and Competitive Landscape - 2017" report has been added to Research and Markets' offering.

Europe Non-Small Cell Lung Cancer Market and Competitive Landscape - 2017, provides comprehensive insights into Non-Small Cell Lung Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Non-Small Cell Lung Cancer market size and drug sales. This research also provides insights into Non-Small Cell Lung Cancer epidemiology and late stage pipeline.

The report is classified into nine sections - Non-Small Cell Lung Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Non-Small Cell Lung Cancer pipeline insights covering late stage clinical trials pipeline; Non-Small Cell Lung Cancer prevalence trends by countries; Non-Small Cell Lung Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

  • Non-Small Cell Lung Cancer pipeline: Find out the drugs in clinical trials for Non-Small Cell Lung Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Non-Small Cell Lung Cancer epidemiology: Find out the prevalence of Non-Small Cell Lung Cancer by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Non-Small Cell Lung Cancer products: Identify key products marketed and prescribed for Non-Small Cell Lung Cancer by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Non-Small Cell Lung Cancer market size: Find out the market size for Non-Small Cell Lung Cancer drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Non-Small Cell Lung Cancer drug sales: Find out the sales of Non-Small Cell Lung Cancer drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Non-Small Cell Lung Cancer drugs sales forecast: Sales forecast for Non-Small Cell Lung Cancer drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Non-Small Cell Lung Cancer market share analysis: Find out the market shares of Non-Small Cell Lung Cancer drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan

For more information about this report visit https://www.researchandmarkets.com/research/vn5nbj/europe_nonsmall

View source version on businesswire.com: http://www.businesswire.com/news/home/20171130006022/en/

Business Wire
www.businesswire.com

Last updated on: 30/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.